Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea (RAPID)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by University of Nottingham
Sponsor:
Collaborator:
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
University of Nottingham
ClinicalTrials.gov Identifier:
NCT01670149
First received: August 17, 2012
Last updated: May 22, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)